Table 3 CNV classification using ACMG/ClinGen framework.

From: Characterization of clinically relevant copy-number variants from exomes of patients with inherited heart disease and unexplained sudden cardiac death

Family

Diagnosis

CNV class

Clinically relevant gene

Interpretation of CNV

ACMG/ClinGen Criteria (score)

Total Score

Classification

CMD

HCM

Intergenic deletion

MYBPC3

ClinGen haploinsufficiency score 3; nonspecific phenotype consistent with similar cases

2D-4 (0.9) 5G (0.1)

1.0

Pathogenic

NSW76A

SUD

Intergenic deletion

KCNH2

ClinGen haploinsufficiency score 3; nonspecific phenotype consistent with similar cases

2A (1.0) 5G (0.1)

1.1

Pathogenic

CBD

DCM

Intragenic deletion

TTN

De novo truncating variant in our patient and in literature; truncating variant burden in DCM; multiple segregations reported for truncating variants

4C (0.1) 4M (0.45) 4H (0.45) 5A (0.15)

1.15

Pathogenic

AHM

LVNC

Intragenic deletion

ACTN2

Truncating variant burden in LVNC; nonspecific phenotype consistent with similar cases

4M (0.3) 5G (0.1)

0.4

VUS

AYQ

HCM

Tandem partial-gene duplication

MYH7

Similarly affected family members with 7 segregations; nonspecific phenotype consistent with similar cases

4H (0.45) 5G (0.1)

0.55

VUS

CBT

LVNC

Duplication

RBM20

Truncating variant burden in LVNC; nonspecific phenotype consistent with similar cases

4M (0.3) 5G (0.1)

0.4

VUS

BLX

LQTS

Duplication

PLN

No supporting criteria

NA

0

VUS

CIJ

DCM

Intragenic deletion

CTNNA3

Overlap with common population variation

4O (−1.0)

−1

Benign

  1. 2A: CNV overlaps established haploinsufficiency locus; 2D-4: CNV overlaps established haploinsufficiency locus that includes other exons in addition to the last exon—nonsense-mediated decay is expected to occur; 4C: previously reported proband has a phenotype consistent with the haploinsufficiency gene of interest where phenotype is not highly specific; 4H: seven or more observed segregations among affected family members in literature; 4M: statistically significant increase in cases (with nonspecific phenotype) compared with population controls; 4O: CNV overlaps with a common population variation reported in public databases; 5A: CNV arises de novo in proband; 5G: inheritance information is unavailable and patient phenotype is consistent with previous reports but it is nonspecific.
  2. ACMG American College of Medical Genetics and Genomics, CNV copy-number variant, DCM dilated cardiomyopathy, HCM hypertrophic cardiomyopathy, LQTS long QT syndrome, LVNC left ventricular noncompaction, SUD unexplained sudden cardiac death VUS variant of uncertain significance.